On April 15, 2016, the Food and Drug Administration (FDA) released draft guidance that describes the FDA's interpretation of drug compounding standards under Sections 503A and 503B of the Food Drug & Cosmetic Act (FD&C Act)....more
In This Issue:
- Top News
..Obama Administration Delays Employer Mandate One Year
..House Energy and Commerce Committee Releases Draft Legislation for SGR Fix
..CMS Proposes Payment Changes for Medicare...more
7/11/2013
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Competitive Bidding ,
Contraceptive Coverage Mandate ,
Contraceptives ,
Delays ,
Department of Health and Human Services (HHS) ,
Drug Distribution ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Home Health Care ,
Medicaid ,
Medical Devices ,
Medicare ,
OIG ,
Over-the-Counter Sales ,
Pay or Play ,
Pharmaceutical Industry ,
Prescription Drugs